Tirzepatide has been approved in Europe and the US for weight loss and weight management in individuals 18 years and over with a BMI of 30 or more or a BMI of 27 or more and at least one weight related health problem such as pre-diabetes, high blood pressure or high cholesterol
Participants could not tell if they had the sham or real procedure because there are not a lot of symptoms after the procedure." Why the Gut Is Key to Weight Regulation The treatment targets the small intestine, where many of the hormones affected by GLP-1 drugs are produced
Bibcode:2012CSRev..41.1499F
Over time, that pooling puts sustained pressure on the vein walls and surrounding tissue, producing the symptoms most people recognize: twisted, rope-like varicose veins, smaller spider veins, persistent leg swelling, aching, skin discoloration, and in advanced cases, open sores called venous ulcers